ID   NEK4_HUMAN              Reviewed;         841 AA.
AC   P51957; A5YM70; B2R633; B7Z200; Q6P576;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   05-MAY-2009, sequence version 2.
DT   12-OCT-2022, entry version 195.
DE   RecName: Full=Serine/threonine-protein kinase Nek4;
DE            EC=2.7.11.1 {ECO:0000250|UniProtKB:Q9Z1J2};
DE   AltName: Full=Never in mitosis A-related kinase 4;
DE            Short=NimA-related protein kinase 4;
DE   AltName: Full=Serine/threonine-protein kinase 2;
DE   AltName: Full=Serine/threonine-protein kinase NRK2;
GN   Name=NEK4; Synonyms=STK2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANT ALA-225, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Mammary gland;
RX   PubMed=8208544;
RA   Levedakou E.N., He M., Baptist E.W., Craven R.J., Cance W.G., Welcsh P.L.,
RA   Simmons A., Naylor S.L., Leach R.J., Lewis T.B., Bowcock A., Liu E.T.;
RT   "Two novel human serine/threonine kinases with homologies to the cell cycle
RT   regulating Xenopus MO15, and NIMA kinases: cloning and characterization of
RT   their expression pattern.";
RL   Oncogene 9:1977-1988(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT ALA-225.
RA   Schupp I.;
RL   Submitted (APR-2007) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Amygdala, and Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R., Buhay C.J.,
RA   Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P.,
RA   Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J., Jackson A.,
RA   Khan Z.M., Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Morgan M.B., Nazareth L.V., Scott G.,
RA   Sodergren E., Song X.-Z., Steffen D., Wei S., Wheeler D.A., Wright M.W.,
RA   Worley K.C., Yuan Y., Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M.,
RA   Brown M.J., Chen G., Chen Z., Clendenning J., Clerc-Blankenburg K.P.,
RA   Chen R., Chen Z., Davis C., Delgado O., Dinh H.H., Dong W., Draper H.,
RA   Ernst S., Fu G., Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J.,
RA   Hao B., Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W.,
RA   Jackson L.R., Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B.,
RA   Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O.,
RA   Palmeiri A., Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J., Zhang X.,
RA   Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H., Reinhardt R.,
RA   Naylor S.L., Yang H., Olson M., Weinstock G., Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT ALA-225.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-563, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [8]
RP   INTERACTION WITH RPGRIP1 AND RPGRIP1L, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=21685204; DOI=10.1093/hmg/ddr280;
RA   Coene K.L., Mans D.A., Boldt K., Gloeckner C.J., van Reeuwijk J., Bolat E.,
RA   Roosing S., Letteboer S.J., Peters T.A., Cremers F.P., Ueffing M.,
RA   Roepman R.;
RT   "The ciliopathy-associated protein homologs RPGRIP1 and RPGRIP1L are linked
RT   to cilium integrity through interaction with Nek4 serine/threonine
RT   kinase.";
RL   Hum. Mol. Genet. 20:3592-3605(2011).
RN   [9]
RP   FUNCTION.
RX   PubMed=22851694; DOI=10.1128/mcb.00436-12;
RA   Nguyen C.L., Possemato R., Bauerlein E.L., Xie A., Scully R., Hahn W.C.;
RT   "Nek4 regulates entry into replicative senescence and the response to DNA
RT   damage in human fibroblasts.";
RL   Mol. Cell. Biol. 32:3963-3977(2012).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-340; SER-343; SER-461 AND
RP   SER-563, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [11]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT LYS-622, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.o113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V., Aguiar M.,
RA   Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C., Vemulapalli V.,
RA   Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [12]
RP   VARIANTS [LARGE SCALE ANALYSIS] ALA-225; GLY-239; LEU-250; ILE-357;
RP   GLU-456; LEU-567 AND LYS-777.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Protein kinase that seems to act exclusively upon threonine
CC       residues (By similarity). Required for normal entry into proliferative
CC       arrest after a limited number of cell divisions, also called
CC       replicative senescence. Required for normal cell cycle arrest in
CC       response to double-stranded DNA damage. {ECO:0000250|UniProtKB:Q9Z1J2,
CC       ECO:0000269|PubMed:22851694}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC         Evidence={ECO:0000250|UniProtKB:Q9Z1J2};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1; Evidence={ECO:0000250|UniProtKB:Q9Z1J2};
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000250|UniProtKB:Q9Z1J2};
CC   -!- SUBUNIT: Interacts with RPGRIP1 and RPGRIP1L.
CC       {ECO:0000269|PubMed:21685204}.
CC   -!- SUBCELLULAR LOCATION: Cell projection, cilium
CC       {ECO:0000269|PubMed:21685204}. Cytoplasm {ECO:0000269|PubMed:21685204}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P51957-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P51957-2; Sequence=VSP_037123, VSP_037124;
CC       Name=3;
CC         IsoId=P51957-3; Sequence=VSP_043334;
CC   -!- TISSUE SPECIFICITY: Highest expression in adult heart, followed by
CC       pancreas, skeletal muscle, brain, testis, retina, liver, kidney, lung
CC       and placenta. Present in most primary carcinomas.
CC       {ECO:0000269|PubMed:21685204, ECO:0000269|PubMed:8208544}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. NEK Ser/Thr
CC       protein kinase family. NIMA subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L20321; AAA36658.1; -; mRNA.
DR   EMBL; EF560744; ABQ59054.1; -; mRNA.
DR   EMBL; AK294165; BAH11686.1; -; mRNA.
DR   EMBL; AK312420; BAG35330.1; -; mRNA.
DR   EMBL; AC006254; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC104446; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC063044; AAH63044.1; -; mRNA.
DR   CCDS; CCDS2863.1; -. [P51957-1]
DR   CCDS; CCDS54593.1; -. [P51957-3]
DR   CCDS; CCDS87089.1; -. [P51957-2]
DR   PIR; I78885; I78885.
DR   RefSeq; NP_001180462.1; NM_001193533.2. [P51957-3]
DR   RefSeq; NP_001335342.1; NM_001348413.1. [P51957-2]
DR   RefSeq; NP_003148.2; NM_003157.5. [P51957-1]
DR   AlphaFoldDB; P51957; -.
DR   SMR; P51957; -.
DR   BioGRID; 112663; 565.
DR   IntAct; P51957; 554.
DR   MINT; P51957; -.
DR   STRING; 9606.ENSP00000233027; -.
DR   BindingDB; P51957; -.
DR   ChEMBL; CHEMBL5819; -.
DR   DrugBank; DB12010; Fostamatinib.
DR   GlyGen; P51957; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; P51957; -.
DR   PhosphoSitePlus; P51957; -.
DR   BioMuta; NEK4; -.
DR   DMDM; 229462924; -.
DR   EPD; P51957; -.
DR   jPOST; P51957; -.
DR   MassIVE; P51957; -.
DR   MaxQB; P51957; -.
DR   PaxDb; P51957; -.
DR   PeptideAtlas; P51957; -.
DR   PRIDE; P51957; -.
DR   ProteomicsDB; 56459; -. [P51957-1]
DR   ProteomicsDB; 56460; -. [P51957-2]
DR   ProteomicsDB; 56461; -. [P51957-3]
DR   Antibodypedia; 14725; 224 antibodies from 28 providers.
DR   DNASU; 6787; -.
DR   Ensembl; ENST00000233027.10; ENSP00000233027.5; ENSG00000114904.13. [P51957-1]
DR   Ensembl; ENST00000383721.8; ENSP00000373227.4; ENSG00000114904.13. [P51957-2]
DR   Ensembl; ENST00000535191.5; ENSP00000437703.1; ENSG00000114904.13. [P51957-3]
DR   GeneID; 6787; -.
DR   KEGG; hsa:6787; -.
DR   MANE-Select; ENST00000233027.10; ENSP00000233027.5; NM_003157.6; NP_003148.2.
DR   UCSC; uc003dfq.5; human. [P51957-1]
DR   CTD; 6787; -.
DR   DisGeNET; 6787; -.
DR   GeneCards; NEK4; -.
DR   HGNC; HGNC:11399; NEK4.
DR   HPA; ENSG00000114904; Tissue enhanced (testis).
DR   MIM; 601959; gene.
DR   neXtProt; NX_P51957; -.
DR   OpenTargets; ENSG00000114904; -.
DR   PharmGKB; PA31548; -.
DR   VEuPathDB; HostDB:ENSG00000114904; -.
DR   eggNOG; KOG0589; Eukaryota.
DR   GeneTree; ENSGT00940000157448; -.
DR   HOGENOM; CLU_017439_0_0_1; -.
DR   InParanoid; P51957; -.
DR   OMA; SRQRWQK; -.
DR   OrthoDB; 70360at2759; -.
DR   PhylomeDB; P51957; -.
DR   TreeFam; TF106472; -.
DR   PathwayCommons; P51957; -.
DR   SignaLink; P51957; -.
DR   BioGRID-ORCS; 6787; 13 hits in 1113 CRISPR screens.
DR   ChiTaRS; NEK4; human.
DR   GenomeRNAi; 6787; -.
DR   Pharos; P51957; Tchem.
DR   PRO; PR:P51957; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   RNAct; P51957; protein.
DR   Bgee; ENSG00000114904; Expressed in bronchial epithelial cell and 198 other tissues.
DR   ExpressionAtlas; P51957; baseline and differential.
DR   Genevisible; P51957; HS.
DR   GO; GO:0005929; C:cilium; IEA:UniProtKB-SubCell.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0030145; F:manganese ion binding; ISS:UniProtKB.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; ISS:UniProtKB.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0006974; P:cellular response to DNA damage stimulus; IMP:UniProtKB.
DR   GO; GO:0000278; P:mitotic cell cycle; IMP:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; IMP:CACAO.
DR   GO; GO:0006468; P:protein phosphorylation; ISS:UniProtKB.
DR   GO; GO:2000772; P:regulation of cellular senescence; IMP:UniProtKB.
DR   GO; GO:2001020; P:regulation of response to DNA damage stimulus; IMP:CACAO.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Cell cycle; Cell division;
KW   Cell projection; Cytoplasm; Kinase; Magnesium; Metal-binding; Methylation;
KW   Mitosis; Nucleotide-binding; Phosphoprotein; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN           1..841
FT                   /note="Serine/threonine-protein kinase Nek4"
FT                   /id="PRO_0000086425"
FT   DOMAIN          6..261
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          517..700
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        533..557
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        586..609
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        610..625
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        131
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         12..20
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         35
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         165
FT                   /note="Phosphothreonine; by autocatalysis"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         340
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         343
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         461
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         563
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19690332,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         622
FT                   /note="N6-methyllysine"
FT                   /evidence="ECO:0007744|PubMed:24129315"
FT   MOD_RES         723
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Z1J2"
FT   VAR_SEQ         32..120
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_043334"
FT   VAR_SEQ         457..502
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_037123"
FT   VAR_SEQ         813..841
FT                   /note="RLREHMGEKYTTYSVKARQLKFFEENMNF -> SVSLTVSRCLCYRIF (in
FT                   isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_037124"
FT   VARIANT         225
FT                   /note="P -> A (in dbSNP:rs1029871)"
FT                   /evidence="ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:8208544,
FT                   ECO:0000269|Ref.2"
FT                   /id="VAR_040915"
FT   VARIANT         239
FT                   /note="R -> G (in dbSNP:rs35778416)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040916"
FT   VARIANT         250
FT                   /note="P -> L (in dbSNP:rs56408749)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040917"
FT   VARIANT         357
FT                   /note="T -> I (in dbSNP:rs2230537)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040918"
FT   VARIANT         456
FT                   /note="Q -> E (in dbSNP:rs56019351)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040919"
FT   VARIANT         567
FT                   /note="F -> L (in dbSNP:rs34986855)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040920"
FT   VARIANT         777
FT                   /note="R -> K (in a colorectal adenocarcinoma sample;
FT                   somatic mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040921"
FT   CONFLICT        63
FT                   /note="P -> L (in Ref. 3; BAG35330)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        64
FT                   /note="N -> D (in Ref. 2; ABQ59054)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        333
FT                   /note="R -> K (in Ref. 3; BAG35330)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   841 AA;  94597 MW;  43E8F11BA4007263 CRC64;
     MPLAAYCYLR VVGKGSYGEV TLVKHRRDGK QYVIKKLNLR NASSRERRAA EQEAQLLSQL
     KHPNIVTYKE SWEGGDGLLY IVMGFCEGGD LYRKLKEQKG QLLPENQVVE WFVQIAMALQ
     YLHEKHILHR DLKTQNVFLT RTNIIKVGDL GIARVLENHC DMASTLIGTP YYMSPELFSN
     KPYNYKSDVW ALGCCVYEMA TLKHAFNAKD MNSLVYRIIE GKLPPMPRDY SPELAELIRT
     MLSKRPEERP SVRSILRQPY IKRQISFFLE ATKIKTSKNN IKNGDSQSKP FATVVSGEAE
     SNHEVIHPQP LSSEGSQTYI MGEGKCLSQE KPRASGLLKS PASLKAHTCK QDLSNTTELA
     TISSVNIDIL PAKGRDSVSD GFVQENQPRY LDASNELGGI CSISQVEEEM LQDNTKSSAQ
     PENLIPMWSS DIVTGEKNEP VKPLQPLIKE QKPKDQSLAL SPKLECSGTI LAHSNLRLLG
     SSDSPASASR VAGITGVCHH AQDQVAGECI IEKQGRIHPD LQPHNSGSEP SLSRQRRQKR
     REQTEHRGEK RQVRRDLFAF QESPPRFLPS HPIVGKVDVT STQKEAENQR RVVTGSVSSS
     RSSEMSSSKD RPLSARERRR LKQSQEEMSS SGPSVRKASL SVAGPGKPQE EDQPLPARRL
     SSDCSVTQER KQIHCLSEDE LSSSTSSTDK SDGDYGEGKG QTNEINALVQ LMTQTLKLDS
     KESCEDVPVA NPVSEFKLHR KYRDTLILHG KVAEEAEEIH FKELPSAIMP GSEKIRRLVE
     VLRTDVIRGL GVQLLEQVYD LLEEEDEFDR EVRLREHMGE KYTTYSVKAR QLKFFEENMN
     F
//
